Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients

Uri H. Lewinski; Giora M. Mavligit; W. Joseph Thompson; Evan M. Hersh; Richard A. Ortez

doi:10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1

Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients

Uri H. Lewinski, Giora M. Mavligit, W. Joseph Thompson, Evan M. Hersh, Richard A. Ortez

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Lymphocyte cyclic nucleotide content was studied before and after Levamisole administration to cancer patients. Twelve patients with disseminated cancer received 100 mg/m² on two consecutive days; nine comparable patients with disseminated cancer served as controls. Endogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were measured in lymphocytes before, 24, and 48 hours after ingestion of the first dose of Levamisole. A statistically significant decline in lymphocyte cAMP level was observed after drug administration and no significant changes were noted in cGMP levels. Further studies will be necessary to correlate this biochemical change in cyclic nucleotides with modulation of the functional level of cellular immune mechanisms.

Original language	English (US)
Pages (from-to)	1280-1283
Number of pages	4
Journal	Cancer
Volume	44
Issue number	4
DOIs	https://doi.org/10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1
State	Published - Oct 1979
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1

Cite this

@article{246d74a0512e49b2bc9a574a0021f885,

title = "Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients",

abstract = "Lymphocyte cyclic nucleotide content was studied before and after Levamisole administration to cancer patients. Twelve patients with disseminated cancer received 100 mg/m2 on two consecutive days; nine comparable patients with disseminated cancer served as controls. Endogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were measured in lymphocytes before, 24, and 48 hours after ingestion of the first dose of Levamisole. A statistically significant decline in lymphocyte cAMP level was observed after drug administration and no significant changes were noted in cGMP levels. Further studies will be necessary to correlate this biochemical change in cyclic nucleotides with modulation of the functional level of cellular immune mechanisms.",

author = "Lewinski, {Uri H.} and Mavligit, {Giora M.} and Thompson, {W. Joseph} and Hersh, {Evan M.} and Ortez, {Richard A.}",

year = "1979",

month = oct,

doi = "10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1",

language = "English (US)",

volume = "44",

pages = "1280--1283",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients

AU - Lewinski, Uri H.

AU - Mavligit, Giora M.

AU - Thompson, W. Joseph

AU - Hersh, Evan M.

AU - Ortez, Richard A.

PY - 1979/10

Y1 - 1979/10

N2 - Lymphocyte cyclic nucleotide content was studied before and after Levamisole administration to cancer patients. Twelve patients with disseminated cancer received 100 mg/m2 on two consecutive days; nine comparable patients with disseminated cancer served as controls. Endogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were measured in lymphocytes before, 24, and 48 hours after ingestion of the first dose of Levamisole. A statistically significant decline in lymphocyte cAMP level was observed after drug administration and no significant changes were noted in cGMP levels. Further studies will be necessary to correlate this biochemical change in cyclic nucleotides with modulation of the functional level of cellular immune mechanisms.

AB - Lymphocyte cyclic nucleotide content was studied before and after Levamisole administration to cancer patients. Twelve patients with disseminated cancer received 100 mg/m2 on two consecutive days; nine comparable patients with disseminated cancer served as controls. Endogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were measured in lymphocytes before, 24, and 48 hours after ingestion of the first dose of Levamisole. A statistically significant decline in lymphocyte cAMP level was observed after drug administration and no significant changes were noted in cGMP levels. Further studies will be necessary to correlate this biochemical change in cyclic nucleotides with modulation of the functional level of cellular immune mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0018591911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018591911&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1

DO - 10.1002/1097-0142(197910)44:4<1280::AID-CNCR2820440417>3.0.CO;2-1

M3 - Article

C2 - 227560

AN - SCOPUS:0018591911

SN - 0008-543X

VL - 44

SP - 1280

EP - 1283

JO - Cancer

JF - Cancer

IS - 4

ER -

Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this